FERROPORTIN INHIBITORS AND METHODS OF USE
The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of di...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
18.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis.
L'invention concerne des composés inhibiteurs de ferroportine de formule I et des sels pharmaceutiques de ceux-ci, des procédés de préparation des composés, des compositions pharmaceutiques comprenant les composés et des procédés d'administration des composés pour la prophylaxie et/ou le traitement de maladies provoquées par un manque d'hepcidine ou des troubles du métabolisme du fer, en particulier des états de surcharge en fer, tels que la thalassémie, la drépanocytose et l'hémochromatose. |
---|---|
Bibliography: | Application Number: WO2019US66053 |